Chen Lab Publishes in Cancer Cell

September 22, 2014

In a study that sheds light on how phospholipid signals are controlled during tumorigenesis, the Chen Lab reports that TIPE3, a newly described oncogenic protein, is the transfer protein of phosphoinositide second messengers that promote cancer.

Read more

Penn Medicine and Wistar Receive $12 Million NCI Melanoma Grant

September 17, 2014

Melanoma physicians and researchers from Penn Medicine and The Wistar Institute have been awarded a prestigious $12.1 million NCI SPORE grant. 

Read more

Residency Program Rankings

September 12, 2014

Penn's Pathology Residency Program was ranked #2 in the nation for residents with a research focus, either translational or basic, and #1 for residents interested in basic and clinical research and fellowships in Neuropathology or Transfusion Medicine. In addition, the program ranked in the top 5 for residents interested in academic careers and Hematopathology, Molecular Genetics, and Cytopathology. 

Read more

Center for Advanced Cellular Therapeutics (CACT)

September 11, 2014

Construction of a first-of-its-kind Center for Advanced Cellular Therapeutics at Penn Medicine has begun.

Read more

New Hematopathology Faculty Member

September 04, 2014

Rachel L. Sargent, MD, a graduate of the Residency Program, has joined the Department as Assistant Professor and Attending Physician in the Section of Hematopathology. 

Read more

Top 50 Most Influential People in Vaccines

August 31, 2014

Dr. David Weiner is among the 2014 Top 50 "Most Influential People in Vaccines." Dr. Weiner’s research in the area of Molecular Immunology has focused extensively on the development of gene-based vaccines and immune therapies.

Read more

Orphan Status for Rare Blood Disorder Drug Developed by the Lambris Lab

August 28, 2014

A drug developed by the Lambris Lab has received orphan status in Europe for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis.

Read more

Gene Therapy Approach for New Treatment of Rare Disease MPS I

August 28, 2014

The lab of James M. Wilson, MD, PhD, director of the Penn Gene Therapy Program, has published a proof-of-principle animal study that reduces harmful accumulation of proteins in a rare lysosomal storage disease through direct gene therapy.

Read more

Apheresis/Infusion Unit Expansion

August 08, 2014

Grand Opening Celebration, Wednesday, September 3, from 4 to 6 pm, in 3 White.

Read more

Pages